181 related articles for article (PubMed ID: 38194089)
41. Treatment outcomes and time to healing of medication-related osteonecrosis of the jaw based on image findings.
Yasui T; Nagamine H; Tanaka K; Kimura M; Karube T; Kawana H; Onizawa K
Dentomaxillofac Radiol; 2023 Jul; 52(5):20220352. PubMed ID: 37192041
[TBL] [Abstract][Full Text] [Related]
42. A preliminary clinical study of segmental mandibulectomy on medication-related osteonecrosis of the jaw.
Otsuru M; Soutome S; Hayashida S; Rokutanda S; Yanamoto S; Umeda M
J Dent Sci; 2022 Jan; 17(1):444-450. PubMed ID: 35028069
[TBL] [Abstract][Full Text] [Related]
43. Medication-related osteonecrosis of the jaw after once-a-year intravenous zoledronic acid infusion for osteoporosis: Report of eight cases.
Favia G; Tempesta A; Limongelli L; Crincoli V; Maiorano E
Quintessence Int; 2016; 47(5):433-40. PubMed ID: 26665262
[TBL] [Abstract][Full Text] [Related]
44. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
Dodson TB
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
[TBL] [Abstract][Full Text] [Related]
45. The Prevention of Medication-related Osteonecrosis of the Jaw.
Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
[TBL] [Abstract][Full Text] [Related]
46. Retrospective Analysis of Treatment Outcomes of Maxillary Sinusitis Associated with Medication-Related Osteonecrosis of the Jaw.
Otsuru M; Hayashida S; Morishita K; Murata M; Soutome S; Sasaki M; Takagi Y; Sumi M; Umeda M
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742679
[TBL] [Abstract][Full Text] [Related]
47. Bisphosphonate application and volumetric effects on MRONJ lesions.
Lentzen MP; Buller J; Riekert M; Grandoch A; Kreppel M; Zöller JE; Zirk M
J Craniomaxillofac Surg; 2021 Jun; 49(6):501-507. PubMed ID: 33853745
[TBL] [Abstract][Full Text] [Related]
48. One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost-benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ).
Fusco V; Campisi G; Bedogni A
Support Care Cancer; 2022 Sep; 30(9):7047-7051. PubMed ID: 35312858
[TBL] [Abstract][Full Text] [Related]
49. Denosumab-related osteonecrosis of the jaw: a report of 2 cases and review of the literature.
Chehal H; Nikitakis NG; Islam MN; Goodchild JH; Mordini L; Bhattacharyya I
Gen Dent; 2019; 67(1):42-46. PubMed ID: 30644830
[TBL] [Abstract][Full Text] [Related]
50. Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan.
Kunihara T; Tohmori H; Tsukamoto M; Kobayashi M; Okumura T; Teramoto H; Hamasaki T; Yamasaki T; Nakagawa T; Okimoto N; Fujiwara S
Osteoporos Int; 2023 Jun; 34(6):1101-1109. PubMed ID: 37002373
[TBL] [Abstract][Full Text] [Related]
51. [Management of medication-related osteonecrosis of the jaw-a review of recent study results in comparison to established strategies].
Tröltzsch M; Tröltzsch M; Pautke C; Otto S
HNO; 2022 Jul; 70(7):499-507. PubMed ID: 35050392
[TBL] [Abstract][Full Text] [Related]
52. Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis.
Dos Santos Ferreira L; Abreu LG; Calderipe CB; Martins MD; Schuch LF; Vasconcelos ACU
Osteoporos Int; 2021 Dec; 32(12):2449-2459. PubMed ID: 34331067
[TBL] [Abstract][Full Text] [Related]
53. Comparing the Surgical Response of Bisphosphonate-Related Versus Denosumab-Related Osteonecrosis of the Jaws.
Palla B; Burian E; Deek A; Scott C; Anderson J; Callahan N; Carlson ER
J Oral Maxillofac Surg; 2021 May; 79(5):1045-1052. PubMed ID: 33358707
[TBL] [Abstract][Full Text] [Related]
54. The Type of Antiresorptive Treatment Influences the Time to Onset and the Surgical Outcome of Medication-Related Osteonecrosis of the Jaw.
Pautke C; Wick A; Otto S; Hohlweg-Majert B; Hoffmann J; Ristow O
J Oral Maxillofac Surg; 2021 Mar; 79(3):611-621. PubMed ID: 33166522
[TBL] [Abstract][Full Text] [Related]
55. Drug holiday clinical relevance verification for antiresorptive agents in medication-related osteonecrosis cases of the jaw.
Hayashida S; Yanamoto S; Fujita S; Hasegawa T; Komori T; Kojima Y; Miyamoto H; Shibuya Y; Ueda N; Kirita T; Nakahara H; Shinohara M; Kondo E; Kurita H; Umeda M
J Bone Miner Metab; 2020 Jan; 38(1):126-134. PubMed ID: 31410544
[TBL] [Abstract][Full Text] [Related]
56. Medication-Related Osteonecrosis of the Jaw in Cancer Patients: Result from the OneFlorida Clinical Research Consortium.
Yang G; Williams R; Wang L; Farhadfar N; Chen Y; Loiacono AT; Bian J; Holliday LS; Katz J; Gong Y
J Bone Miner Res; 2022 Dec; 37(12):2466-2471. PubMed ID: 36151778
[TBL] [Abstract][Full Text] [Related]
57. Texture analysis using short-tau inversion recovery magnetic resonance images to differentiate squamous cell carcinoma of the gingiva from medication-related osteonecrosis of the jaw.
Ito K; Hirahara N; Muraoka H; Sawada E; Tokunaga S; Kaneda T
Oral Radiol; 2024 Apr; 40(2):219-225. PubMed ID: 38060046
[TBL] [Abstract][Full Text] [Related]
58. Medication-related osteonecrosis of the mandible: an unusual presentation and treatment.
Rothweiler R; Voss PJ; Schmelzeisen R; Metzger MC
Int J Oral Maxillofac Surg; 2021 Apr; 50(4):511-515. PubMed ID: 32847710
[TBL] [Abstract][Full Text] [Related]
59. Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study.
Hasegawa T; Hayashida S; Kondo E; Takeda Y; Miyamoto H; Kawaoka Y; Ueda N; Iwata E; Nakahara H; Kobayashi M; Soutome S; Yamada SI; Tojyo I; Kojima Y; Umeda M; Fujita S; Kurita H; Shibuya Y; Kirita T; Komori T;
Osteoporos Int; 2019 Jan; 30(1):231-239. PubMed ID: 30406309
[TBL] [Abstract][Full Text] [Related]
60. Three-dimensional clinical assessment for MRONJ risk in oncologic patients following tooth extractions.
Moreno Rabie C; Cavalcante Fontenele R; Oliveira Santos N; Nogueira Reis F; Van den Wyngaert T; Jacobs R
Dentomaxillofac Radiol; 2023 Nov; 52(8):20230238. PubMed ID: 37874081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]